Cartilage Repair/Regeneration Market Size, Trends and Insights By Treatment Modality (Cell-Based, Non-Cell-Based), By Application (Fibrocartilage, Hyaline Cartilage), By Treatment (Palliative, Intrinsic Repair Stimulus), By Site (Knee, Ankle, Spine, Hip, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Smith & Nephew plc
- Zimmer Biomet
- DePuy Synthes
- Stryker Corporation
- Others
Reports Description
According to Custom Market Insights (CMI), The Global Cartilage Repair/Regeneration Market size was estimated at USD 0.75 billion in 2021 and is expected to reach USD 1.2 billion in 2022 and is anticipated to reach around USD 2.32 billion by 2030, growing at a CAGR of roughly 15% between 2022 and 2030.
Our research report offers a 360-degree view of the Cartilage Repair/Regeneration market’s drivers and restraints, coupled with their impact on demand during the projection period. Also, the report examines global opportunities and competitive analysis for the Cartilage Repair/Regeneration market.
- Cartilage repair and regeneration is the recommended course of treatment for healthy but damaged cartilage. The cartilage is harmed by injury, which impairs function and hurts. Direct strikes, gradual deterioration, and trauma are some of the factors that lead to articular cartilage injuries. As the cartilage eventually loses both its structure and function, it degenerates. Lack of blood supply is one of the factors that might cause cartilage injury.
- Early adoption of cartilage restoration or regeneration techniques can stop the onset of osteoarthritis. The market can be divided into two categories based on the application: fibrocartilage repair and regeneration and hyaline cartilage repair and regeneration. Cell-Based Approaches, Growth Factor Technology, Stem Cells, Chondrocyte Transplantation, Non-Cell-Based Approaches, Cell-Free Composites, and Tissue Scaffolds are a few examples of different types of treatment modalities.
- During the COVID-19 epidemic, the cartilage repair and regeneration market plummeted. Early market decreases in cartilage repair/regeneration are anticipated throughout the forecast period as a result of lockdowns, a lack of wound care services, and postponed or canceled elective surgeries, among other causes. A large increase in demand for products that support cartilage repair/regeneration is projected in the second half of the forecast period.
- Individuals with COVID-19 had their elective surgeries rejected (canceled/postponed) in order to reserve or devote limited capacity and resources (such as hospital beds and medical staff) toward treating patients undergoing elective procedures. To combat the surge in COVID-19 cases, curfews and lockdowns have also been enforced in a number of countries.
- This lockout prevented patients from entering hospitals or outpatient clinics. In the first half of the projected period, cancer care operations and therapies, temporary denial of wound care services, as well as other healthcare services are predicted to restrain the growth of the cartilage repair and regeneration market. However, it is projected that this need will greatly increase in 2022.
Report Scope
The study focuses on Cartilage Repair/Regeneration market analysis on a global scale, and market sizing includes the income generated by these solutions provided by different market players. To support the market projections and growth rates over the anticipated 2022-2030, the study monitors essential market factors, underlying growth influencers, and significant vendors active in the sector. The study also examines how COVID-19 has affected the ecology generally. The scope of the study includes market sizing and forecast for segmentation by treatment modality, application, treatment, site, and geography.
| Feature of the Report | Details |
| Market Size in 2021 | USD 0.75 Billion |
| Projected Market Size in 2030 | USD 2.32 Billion |
| Market Size in 2022 | USD 1.2 Billion |
| CAGR Growth Rate | 15% CAGR (2022-2030) |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Prominent Players | Smith & Nephew plc, Zimmer Biomet, DePuy Synthes, Stryker Corporation, B. Braun Melsungen AG, Vericel Corporation, Anika Therapeutics, MEDIPOST Co.Ltd., RTI Surgical (RTI), Arthrex, Inc., CONMED CORPORATION, Regrow Biosciences PVT.LTD, Geistlich Pharma AG, Orthocell Ltd, AlloSource, Bio-Tissue, and Others |
| Key Segment | By Treatment Modality, Application, Treatment, Site, and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Key Market Dynamics
- The projected period is expected to see a slowdown in the market growth for cartilage repair due to the rising rates of diabetes and obesity around the world. Diabetes accelerates the loss of cartilage. Additionally, a rise in the proportion of obese (overweight) people is anticipated during the predicted period, especially in Latin America and the MEA region.
- The global geriatric population, which is susceptible to chronic diseases and is anticipated to be a significant driver of the rise in cartilage repair procedures, is predicted by the American Heart Association (AHA) to account for approximately 20.0% of the total population by 2030. This population is expected to support the market during the forecast period.
- Demand for cartilage repair products is expected to grow over the projection period as road accidents and sports-related injuries that cause bone and joint injuries are expected to increase.
- Government financing for research in regenerative medicine for cartilage regeneration has resulted in a sharp increase in the number of companies making products for cartilage regeneration in recent years. These factors have stimulated more clinical research and the development of fresh cartilage regeneration treatments. There is a robust pipeline of products based on various procedures for cartilage restoration now available on the market thanks to significant investments made in R&D by major companies in this sector.
Knee Application Segment Led the Cartilage Repair/Regeneration Market
- The knee’s largest joint, the knee, carries most of the body’s weight as a person walks. A common injury that frequently impacts the knees is cartilage damage. Due to factors such as a rise in knee replacements, knee implants, and the rising incidence of osteoarthritis, the knee segment is predicted to expand over the forecast period. For instance, 67 million individuals are expected to have arthritis in 2025, according to data from National Arthritis Prevalence Projections. By 2040, 78 million people are anticipated to fall under this category.
- The market is growing as a result of increased R&D, the introduction of new products, mergers, and acquisitions. For example, Minor League Baseball and Stryker collaborated to formally name Stryker as SmartRobotics’ joint replacement partner in April 2021. Mako SmartRobotics, the newest collaborative replacement technology from Stryker, uses 3D CT-based planning software to replace the hip and knee. It aids surgeons in building a 3D model of each patient’s particular anatomy. Additionally, in June 2021, Swiss company Mathys AG Bettlach, which creates and sells cutting-edge artificial joint replacement solutions, was purchased by DJO, LLC.
Competitive Landscape
The market for cartilage repair/regeneration is competitive and moderately fragmented. By implementing inorganic growth methods, including acquisitions & mergers, partnerships, and joint ventures, market participants in the worldwide Cartilage Repair/ Cartilage Regeneration market are concentrating on expanding their product portfolios.
Our market analysis includes a section specifically devoted to key players operating in the Cartilage Repair/Regeneration market. Our analysts overview each player’s financial statements, product benchmarking, and SWOT analysis. In addition, the competitive landscape section includes key development strategies, market share analysis, and market positioning analysis of globally mentioned competitors.
- 2022: For a clinical investigation using the FibroFix product platform for knee cartilage regeneration, Orthox gained authorization from the Medicines and Healthcare products Regulatory Agency (MHRA).
- 2021: The cartilage system from Hyalex was given breakthrough device classification by the US Food and Drug Administration.
Prominent Players:
- Smith & Nephew plc
- Zimmer Biomet
- DePuy Synthes
- Stryker Corporation
- Braun Melsungen AG
- Vericel Corporation
- Anika Therapeutics
- MEDIPOST Co.Ltd.
- RTI Surgical (RTI)
- Arthrex, Inc.
- CONMED CORPORATION
- Regrow Biosciences PVT.LTD
- Geistlich Pharma AG
- Orthocell Ltd
- AlloSource
- Bio-Tissue
The global Cartilage Repair/Regeneration market is segmented as follows:
By Treatment Modality
- Cell-Based
- Non-Cell-Based
By Application
- Fibrocartilage
- Hyaline Cartilage
By Treatment
- Palliative
- Intrinsic Repair Stimulus
By Site
- Knee
- Ankle
- Spine
- Hip
- Others
On the basis of Geography
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Cartilage Repair/Regeneration Market, (2022 – 2030) (USD Billion)
- 2.2 Global Cartilage Repair/Regeneration Market: snapshot
- Chapter 3. Global Cartilage Repair/Regeneration Market – Industry Analysis
- 3.1 Cartilage Repair/Regeneration Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 The rising incidences of bone & joint disorders like osteoarthritis
- 3.2.2 The growing number of sports injuries
- 3.2.3 Technological advancements in cartilage regeneration
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Treatment Modality
- 3.7.2 Market attractiveness analysis By Application
- 3.7.3 Market attractiveness analysis By Treatment
- 3.7.4 Market attractiveness analysis By Site
- Chapter 4. Global Cartilage Repair/Regeneration Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Cartilage Repair/Regeneration Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Cartilage Repair/Regeneration Market – Treatment Modality Analysis
- 5.1 Global Cartilage Repair/Regeneration Market overview: By Treatment Modality
- 5.1.1 Global Cartilage Repair/Regeneration Market share, By Treatment Modality, 2021 and 2030
- 5.2 Cell-Based
- 5.2.1 Global Cartilage Repair/Regeneration Market by Cell-Based, 2022 – 2030 (USD Billion)
- 5.3 Non-Cell-Based
- 5.3.1 Global Cartilage Repair/Regeneration Market by Non-Cell-Based, 2022 – 2030 (USD Billion)
- 5.1 Global Cartilage Repair/Regeneration Market overview: By Treatment Modality
- Chapter 6. Global Cartilage Repair/Regeneration Market – Application Analysis
- 6.1 Global Cartilage Repair/Regeneration Market overview: By Application
- 6.1.1 Global Cartilage Repair/Regeneration Market share, By Application, 2021 and 2030
- 6.2 Fibrocartilage
- 6.2.1 Global Cartilage Repair/Regeneration Market by Fibrocartilage, 2022 – 2030 (USD Billion)
- 6.3 Hyaline Cartilage
- 6.3.1 Global Cartilage Repair/Regeneration Market by Hyaline Cartilage, 2022 – 2030 (USD Billion)
- 6.1 Global Cartilage Repair/Regeneration Market overview: By Application
- Chapter 7. Global Cartilage Repair/Regeneration Market – Treatment Analysis
- 7.1 Global Cartilage Repair/Regeneration Market overview: By Treatment
- 7.1.1 Global Cartilage Repair/Regeneration Market share, By Treatment, 2021 and 2030
- 7.2 Palliative
- 7.2.1 Global Cartilage Repair/Regeneration Market by Palliative, 2022 – 2030 (USD Billion)
- 7.3 Intrinsic Repair Stimulus
- 7.3.1 Global Cartilage Repair/Regeneration Market by Intrinsic Repair Stimulus, 2022 – 2030 (USD Billion)
- 7.1 Global Cartilage Repair/Regeneration Market overview: By Treatment
- Chapter 8. Global Cartilage Repair/Regeneration Market – Site Analysis
- 8.1 Global Cartilage Repair/Regeneration Market overview: By Site
- 8.1.1 Global Cartilage Repair/Regeneration Market share, By Site, 2021 and 2030
- 8.2 Knee
- 8.2.1 Global Cartilage Repair/Regeneration Market by Knee, 2022 – 2030 (USD Billion)
- 8.3 Ankle
- 8.3.1 Global Cartilage Repair/Regeneration Market by Ankle, 2022 – 2030 (USD Billion)
- 8.4 Spine
- 8.4.1 Global Cartilage Repair/Regeneration Market by Spine, 2022 – 2030 (USD Billion)
- 8.5 Hip
- 8.5.1 Global Cartilage Repair/Regeneration Market by Hip, 2022 – 2030 (USD Billion)
- 8.6 Others
- 8.6.1 Global Cartilage Repair/Regeneration Market by Others, 2022 – 2030 (USD Billion)
- 8.1 Global Cartilage Repair/Regeneration Market overview: By Site
- Chapter 9. Cartilage Repair/Regeneration Industry – Regional Analysis
- 9.1 Global Cartilage Repair/Regeneration Industry Regional Overview
- 9.2 Global Cartilage Repair/Regeneration Industry Share, by Region, 2021 & 2030 (USD Billion)
- 9.3. North America
- 9.3.1 North America Cartilage Repair/Regeneration Industry, 2022 – 2030 (USD Billion)
- 9.3.1.1 North America Cartilage Repair/Regeneration Industry, by Country, 2022 – 2030 (USD Billion)
- 9.3.1 North America Cartilage Repair/Regeneration Industry, 2022 – 2030 (USD Billion)
- 9.4 North America Cartilage Repair/Regeneration Industry, by Treatment Modality, 2022 – 2030
- 9.4.1 North America Cartilage Repair/Regeneration Industry, by Treatment Modality, 2022 – 2030 (USD Billion)
- 9.5 North America Cartilage Repair/Regeneration Industry, by Application, 2022 – 2030
- 9.5.1 North America Cartilage Repair/Regeneration Industry, by Application, 2022 – 2030 (USD Billion)
- 9.6 North America Cartilage Repair/Regeneration Industry, by Treatment, 2022 – 2030
- 9.6.1 North America Cartilage Repair/Regeneration Industry, by Treatment, 2022 – 2030 (USD Billion)
- 9.7 North America Cartilage Repair/Regeneration Industry, by Site, 2022 – 2030
- 9.7.1 North America Cartilage Repair/Regeneration Industry, by Site, 2022 – 2030 (USD Billion)
- 9.8. Europe
- 9.8.1 Europe Cartilage Repair/Regeneration Industry, 2022 – 2030 (USD Billion)
- 9.8.1.1 Europe Cartilage Repair/Regeneration Industry, by Country, 2022 – 2030 (USD Billion)
- 9.8.1 Europe Cartilage Repair/Regeneration Industry, 2022 – 2030 (USD Billion)
- 9.9 Europe Cartilage Repair/Regeneration Industry, by Treatment Modality, 2022 – 2030
- 9.9.1 Europe Cartilage Repair/Regeneration Industry, by Treatment Modality, 2022 – 2030 (USD Billion)
- 9.10 Europe Cartilage Repair/Regeneration Industry, by Application, 2022 – 2030
- 9.10.1 Europe Cartilage Repair/Regeneration Industry, by Application, 2022 – 2030 (USD Billion)
- 9.11 Europe Cartilage Repair/Regeneration Industry, by Treatment, 2022 – 2030
- 9.11.1 Europe Cartilage Repair/Regeneration Industry, by Treatment, 2022 – 2030 (USD Billion)
- 9.12 Europe Cartilage Repair/Regeneration Industry, by Site, 2022 – 2030
- 9.12.1 Europe Cartilage Repair/Regeneration Industry, by Site, 2022 – 2030 (USD Billion)
- 9.13. Asia Pacific
- 9.13.1 Asia Pacific Cartilage Repair/Regeneration Industry, 2022 – 2030 (USD Billion)
- 9.13.1.1 Asia Pacific Cartilage Repair/Regeneration Industry, by Country, 2022 – 2030 (USD Billion)
- 9.13.1 Asia Pacific Cartilage Repair/Regeneration Industry, 2022 – 2030 (USD Billion)
- 9.14 Asia Pacific Cartilage Repair/Regeneration Industry, by Treatment Modality, 2022 – 2030
- 9.14.1 Asia Pacific Cartilage Repair/Regeneration Industry, by Treatment Modality, 2022 – 2030 (USD Billion)
- 9.15 Asia Pacific Cartilage Repair/Regeneration Industry, by Application, 2022 – 2030
- 9.15.1 Asia Pacific Cartilage Repair/Regeneration Industry, by Application, 2022 – 2030 (USD Billion)
- 9.16 Asia Pacific Cartilage Repair/Regeneration Industry, by Treatment, 2022 – 2030
- 9.16.1 Asia Pacific Cartilage Repair/Regeneration Industry, by Treatment, 2022 – 2030 (USD Billion)
- 9.17 Asia Pacific Cartilage Repair/Regeneration Industry, by Site, 2022 – 2030
- 9.17.1 Asia Pacific Cartilage Repair/Regeneration Industry, by Site, 2022 – 2030 (USD Billion)
- 9.18. Latin America
- 9.18.1 Latin America Cartilage Repair/Regeneration Industry, 2022 – 2030 (USD Billion)
- 9.18.1.1 Latin America Cartilage Repair/Regeneration Industry, by Country, 2022 – 2030 (USD Billion)
- 9.18.1 Latin America Cartilage Repair/Regeneration Industry, 2022 – 2030 (USD Billion)
- 9.19 Latin America Cartilage Repair/Regeneration Industry, by Treatment Modality, 2022 – 2030
- 9.19.1 Latin America Cartilage Repair/Regeneration Industry, by Treatment Modality, 2022 – 2030 (USD Billion)
- 9.20 Latin America Cartilage Repair/Regeneration Industry, by Application, 2022 – 2030
- 9.20.1 Latin America Cartilage Repair/Regeneration Industry, by Application, 2022 – 2030 (USD Billion)
- 9.21 Latin America Cartilage Repair/Regeneration Industry, by Treatment, 2022 – 2030
- 9.21.1 Latin America Cartilage Repair/Regeneration Industry, by Treatment, 2022 – 2030 (USD Billion)
- 9.22 Latin America Cartilage Repair/Regeneration Industry, by Site, 2022 – 2030
- 9.22.1 Latin America Cartilage Repair/Regeneration Industry, by Site, 2022 – 2030 (USD Billion)
- 9.23. The Middle-East and Africa
- 9.23.1 The Middle-East and Africa Cartilage Repair/Regeneration Industry, 2022 – 2030 (USD Billion)
- 9.23.1.1 The Middle-East and Africa Cartilage Repair/Regeneration Industry, by Country, 2022 – 2030 (USD Billion)
- 9.23.1 The Middle-East and Africa Cartilage Repair/Regeneration Industry, 2022 – 2030 (USD Billion)
- 9.24 The Middle-East and Africa Cartilage Repair/Regeneration Industry, by Treatment Modality, 2022 – 2030
- 9.24.1 The Middle-East and Africa Cartilage Repair/Regeneration Industry, by Treatment Modality, 2022 – 2030 (USD Billion)
- 9.25 The Middle-East and Africa Cartilage Repair/Regeneration Industry, by Application, 2022 – 2030
- 9.25.1 The Middle-East and Africa Cartilage Repair/Regeneration Industry, by Application, 2022 – 2030 (USD Billion)
- 9.26 The Middle-East and Africa Cartilage Repair/Regeneration Industry, by Treatment, 2022 – 2030
- 9.26.1 The Middle-East and Africa Cartilage Repair/Regeneration Industry, by Treatment, 2022 – 2030 (USD Billion)
- 9.27 The Middle-East and Africa Cartilage Repair/Regeneration Industry, by Site, 2022 – 2030
- 9.27.1 The Middle-East and Africa Cartilage Repair/Regeneration Industry, by Site, 2022 – 2030 (USD Billion)
- Chapter 10. Company Profiles
- 10.1 Smith & Nephew plc
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 Zimmer Biomet
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 DePuy Synthes
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 Stryker Corporation
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 Braun Melsungen AG
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 Vericel Corporation
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 Anika Therapeutics
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 MEDIPOST Co.Ltd.
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 RTI Surgical (RTI)
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 Arthrex, Inc.
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 CONMED CORPORATION
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Regrow Biosciences PVT.LTD
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.13 Geistlich Pharma AG
- 10.13.1 Overview
- 10.13.2 Financials
- 10.13.3 Product Portfolio
- 10.13.4 Business Strategy
- 10.13.5 Recent Developments
- 10.14 Orthocell Ltd
- 10.14.1 Overview
- 10.14.2 Financials
- 10.14.3 Product Portfolio
- 10.14.4 Business Strategy
- 10.14.5 Recent Developments
- 10.15 AlloSource
- 10.15.1 Overview
- 10.15.2 Financials
- 10.15.3 Product Portfolio
- 10.15.4 Business Strategy
- 10.15.5 Recent Developments
- 10.16 Bio-Tissue
- 10.16.1 Overview
- 10.16.2 Financials
- 10.16.3 Product Portfolio
- 10.16.4 Business Strategy
- 10.16.5 Recent Developments
- 10.1 Smith & Nephew plc
List Of Figures
Figures No 1 to 29
List Of Tables
Tables No 1 to 102
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2030
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Players:
- Smith & Nephew plc
- Zimmer Biomet
- DePuy Synthes
- Stryker Corporation
- Braun Melsungen AG
- Vericel Corporation
- Anika Therapeutics
- MEDIPOST Co.Ltd.
- RTI Surgical (RTI)
- Arthrex, Inc.
- CONMED CORPORATION
- Regrow Biosciences PVT.LTD
- Geistlich Pharma AG
- Orthocell Ltd
- AlloSource
- Bio-Tissue
- Others
FAQs
“North America” region will lead the global Cartilage Repair/Regeneration market during the forecast period 2022 to 2030.
The key factors are driving the market: The rising incidences of bone & joint disorders like osteoarthritis, the growing number of sports injuries, and technological advancements in cartilage regeneration are expected to drive the Cartilage Repair-Cartilage Regeneration Market over the predicted years.
The key players operating in the Cartilage Repair/Regeneration market are Smith & Nephew plc, Zimmer Biomet, DePuy Synthes, Stryker Corporation, B. Braun Melsungen AG, Vericel Corporation, Anika Therapeutics, MEDIPOST Co.Ltd., RTI Surgical (RTI), Arthrex, Inc., CONMED CORPORATION, Regrow Biosciences PVT.LTD, Geistlich Pharma AG, Orthocell Ltd, AlloSource, Bio-Tissue.
The global Cartilage Repair/Regeneration market is expanding growth with a CAGR of approximately 15% during the forecast period (2022 to 2030).
The global Cartilage Repair/Regeneration market size was valued at USD 850 Million in 2021 and it is projected to reach around USD 2010 Million by 2030.